NuvemRx
- Company typePrivate
- Founded2014
- HeadquartersSharon Hill, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
NuvemRx firmographics
Firmographics- Name
- NuvemRx
- Legal name
- 340B Technologies, Inc.
- Website
- https://nuvemrx.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
NuvemRx industry classification
Industry- Product category
- 340B Pharmacy Management Services
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Hospital & Medical Service Plans (6324)
- akta.pro primary industry
- Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
Keywords
Where NuvemRx is headquartered
LocationHeadquarters
- HQ city
- Sharon Hill
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
NuvemRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Third-Party Administration (TPA) Services: NuvemRx operates as a Third-Party Administrator (TPA) for 340B programs, providing contract pharmacy management services to covered entities. Revenue is generated through service fees charged to community health centers for managing their 340B pharmacy programs, including claims processing, compliance monitoring, and reporting.
- Entity-Owned Pharmacy Management: NuvemRx provides comprehensive pharmacy management solutions for health centers operating their own in-house pharmacies. Services include pharmacy setup, staffing, operations management, and ongoing optimization, generating recurring service fees.
- Specialty Care Referral Services: Following the par8o acquisition, NuvemRx offers specialty referral management services including referral capture, authorization automation, and network optimization. These services help reduce referral leakage and expand patient access while generating service-based revenue.
- Program Integrity and Compliance Services: Compliance-focused services including quarterly 340B audits, federal audit preparation, and regulatory guidance. These advisory services are bundled with core offerings or provided as standalone consulting engagements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Enterprise pricing for covered entities |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
NuvemRx product offering
Product offeringCore offering
NuvemRx provides 340B pharmacy management services to community health providers through three core offerings: NuTPA (Third-Party Administrator for contract pharmacies), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by par8o). These are delivered on the cloud-based Apollo Platform with AI-powered analytics and supported by the Mission Control expert team, helping covered entities manage compliance, capture savings, and operate pharmacy programs efficiently.
Product overview
NuvemRx offers a unified suite of pharmacy solutions for community health providers built on the Apollo Platform. The core offerings include NuTPA (contract pharmacy third-party administration), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by acquired par8o technology). These products integrate software, intelligence, and expert support through Mission Control to help covered entities manage 340B programs, optimize pharmacy operations, reduce referral leakage, and maintain compliance. The company formed in 2024 from the merger of 340Basics, Apovia, and Louvir, and expanded in 2026 through the acquisition of par8o's 340B referral capture business.
Differentiator
Problem solved
Functional benefit
Brands
- NuTPA: Contract Pharmacy solution providing simplified TPA services, pricing transparency, automated workflows, and expert support for 340B contract pharmacy management.
- NuPharmacy
- NuReferrals
- Mission Control
- Apollo Platform
Products and services
- NuTPA
- NuPharmacy
- NuReferrals
- Apollo Platform
- Mission Control
- Program Integrity Service
Quantifiable outcome
- 800+ covered entities served nationwide with over 70 million cumulative patients
- +5 more outcomes
Companies that use NuvemRx
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles4 records
NuvemRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature8 records
NuvemRx partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered major and core.
- R1 RCMmajorNuvemRx acquired the 340B referral capture business par8o from R1 RCM in February 2026. This acquisition adds AI-powered referral technology and real-time referral visibility to NuvemRx's suite of services. par8o's COO joined NuvemRx's leadership team following the deal. par8o had been acquired by R1 RCM as part of the Cloudmed transaction in 2022.
- 26HealthcoreExpanded partnership with 26Health to open their first entity-owned pharmacy in Orlando, Florida. The new pharmacy aims to improve access, compliance, and efficiency for the community health organization, with savings reinvested into additional community health programs.
Scale indicators8 records
Recent moves8 records
Expansion highlights5 records
NuvemRx competitors and assessment
Company assessmentDirect peers
- Verity Solutions (McKesson): 340B compliance and contract pharmacy software platform, acquired by McKesson. Competes with NuvemRx on automated split-billing, audit support, and 340B program integrity services for health centers and hospitals.
- SunRx: 340B software and TPA platform providing split-billing, contract pharmacy management, and analytics to covered entities. Direct competitor for NuTPA and Apollo Platform capabilities in the same community health customer base.
- CaptureRx: Direct 340B third-party administrator for contract pharmacy programs serving FQHCs and safety-net providers. Competes head-to-head with NuvemRx's NuTPA offering on claims processing, split billing, and compliance services for similar covered-entity customers.
Broad incumbents
- R1 RCM: Healthcare revenue cycle management company that previously owned par8o (the 340B referral capture business NuvemRx acquired in Feb 2026). R1 still services 340B-adjacent workflows for health systems, partially overlapping with NuvemRx's NuReferrals offering.
- RxBenefits: PBM advisory and TPA firm for self-funded employer plans; competes with NuvemRx on third-party administration, claims processing, and pharmacy benefit optimization across a different but related customer segment (employers and payers vs. FQHC covered entities).
- Omnicell: Public pharmacy automation and medication management company whose former leaders now lead NuvemRx (CEO Scott Seidelmann, several VPs). Overlaps with NuvemRx in 340B TPA platform, pharmacy operations software, and adherence tools, but operates across a much broader pharmacy portfolio beyond 340B.
- ConnectiveRx: Tech-enabled patient access and pharmacy services company where NuvemRx's Chief Legal Officer previously served. Comparable in adjacent pharmacy services, manufacturer hub services, and patient affordability programs serving similar healthcare stakeholders.
- CoverMyMeds (McKesson): Electronic prior authorization, e-prescribing, and medication access network within McKesson. Comparable in automating the prescription access workflow that NuvemRx also touches through smart script capture and AI-powered referral tools.
Others
- Apexus: HRSA-contracted prime vendor for the federal 340B Drug Pricing Program. An ecosystem enabler rather than direct competitor — Apexus administers the program's infrastructure that NuvemRx's clients and TPAs rely upon.
- Surescripts: Pharmacy e-prescribing and health information network whose former legal head now serves as NuvemRx's CLO. Adjacent infrastructure provider whose e-prescribing backbone supports the prescription flow that 340B TPAs like NuvemRx process and optimize.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
NuvemRx social profiles
Digital presenceNuvemRx compliance and trust
Trust signalCompliance1 record
NuvemRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
NuvemRx leadership team
Management profileNumber of profiles
Profiles14 records
NuvemRx subsidiaries and ownership
Company hierarchySubsidiaries1 record
NuvemRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NuvemRx M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NuvemRx
What does NuvemRx do?
NuvemRx provides 340B pharmacy management services to community health providers through three core offerings: NuTPA (Third-Party Administrator for contract pharmacies), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by par8o). These are delivered on the cloud-based Apollo Platform with AI-powered analytics and supported by the Mission Control expert team, helping covered entities manage compliance, capture savings, and operate pharmacy programs efficiently.
Is NuvemRx a public or private company?
NuvemRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NuvemRx founded?
NuvemRx was founded in 2014. It employs 251 to 500 people.
Where is NuvemRx based?
NuvemRx is headquartered in Sharon Hill, United States, in the North America region.
How does NuvemRx make money?
Four revenue lines are on record. Third-Party Administration (TPA) Services are the primary driver. The others are entity-Owned Pharmacy Management, specialty Care Referral Services and program Integrity and Compliance Services.
Who are NuvemRx's main competitors?
Direct peers on record are Verity Solutions (McKesson), SunRx and CaptureRx. Broad incumbents are R1 RCM, RxBenefits, Omnicell, ConnectiveRx and CoverMyMeds (McKesson). Others are Apexus and Surescripts.
Does NuvemRx have an API?
No public API is recorded for NuvemRx.
What industry is NuvemRx in?
NuvemRx's product category is 340B Pharmacy Management Services. Its primary akta.pro industry code is HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 524292 and its SIC code is 6324.